Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 8.
L
Liu, Xinxue;
Munro, Alasdair PS;
Feng, Shuo;
Janani, Leila;
Aley, Parvinder K;
Babbage, Gavin;
Baxter, David;
... COV-BOOST study group; + view all
(2022)
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
Journal of Infection
10.1016/j.jinf.2022.04.018.
(In press).
|
 |
M
|
Mead, S;
Khalili-Shirazi, A;
Potter, C;
Mok, T;
Nihat, A;
Hyare, H;
Canning, S;
... Collinge, J; + view all
(2022)
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme.
The Lancet Neurology
, 21
(4)
pp. 342-354.
10.1016/S1474-4422(22)00082-5.
|
|
Mentzer, AJ;
O’Connor, D;
Bibi, S;
Chelysheva, I;
Clutterbuck, EA;
Demissie, T;
Dinesh, T;
... Knight, JC; + view all
(2022)
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Nature Medicine
, 29
(1)
pp. 147-157.
10.1038/s41591-022-02078-6.
|
|
Munro, Alasdair PS;
Feng, Shuo;
Janani, Leila;
Cornelius, Victoria;
Aley, Parvinder K;
Babbage, Gavin;
Baxter, David;
... COV-BOOST study group, .; + view all
(2022)
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
The Lancet Infectious Diseases
10.1016/S1473-3099(22)00271-7.
(In press).
|
N
|
Neueder, Andreas;
Kojer, Kerstin;
Hering, Tanja;
Lavery, Daniel J;
Chen, Jian;
Birth, Nathalie;
Hallitsch, Jaqueline;
... Orth, Michael; + view all
(2022)
Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues.
Genome Biology
, 23
, Article 189. 10.1186/s13059-022-02752-5.
|
S
|
Shaw, Robert H;
Liu, Xinxue;
Stuart, Arabella SV;
Greenland, Melanie;
Aley, Parvinder K;
Andrews, Nick J;
Cameron, J Claire;
... Com-COV Study Group; + view all
(2022)
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
The Lancet Respiratory Medicine
10.1016/S2213-2600(22)00163-1.
|
W
|
Wu, Mary;
Wall, Emma C;
Carr, Edward J;
Harvey, Ruth;
Townsley, Hermaleigh;
Mears, Harriet V;
Adams, Lorin;
... Bauer, David LV; + view all
(2022)
Three-dose vaccination elicits neutralising antibodies against omicron.
The Lancet
, 399
(10326)
pp. 715-717.
10.1016/S0140-6736(22)00092-7.
|
Y
|
Young, Tim;
Ochulor, Juliana;
Bahra, Anish;
(2022)
Letter to the Editor: Very long-term use of Flunarizine for migraine patients—A word of hope and caution.
[Digital scholarly resource].
https://journals.lww.com/md-journal/blog/medicinec...
|
